title: In the interest of full disclosure.
authors.forename: Mark E
authors.initials: ME
authors.lastname: Burkard
authors.forename: Amye J
authors.initials: AJ
authors.lastname: Tevaarwerk
authors.forename: Kari B
authors.initials: KB
authors.lastname: Wisinski
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D015982:Bias; D054316:Biomarkers, Pharmacological; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000494:pharmacology; D004317:Doxorubicin / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000494:pharmacology; D020869:Gene Expression Profiling; D006801:Humans; D016019:Survival Analysis; D013629:Tamoxifen / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D054316:Biomarkers, Pharmacological; D013629:Tamoxifen; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil